Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Margaret A. Niznikiewicz, Ph.D.

Co-Author

This page shows the publications co-authored by Margaret Niznikiewicz and Ofer Pasternak.
Connection Strength

0.808
  1. MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis. Neuroimage. 2021 02 01; 226:117564.
    View in: PubMed
    Score: 0.227
  2. Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology. Psychiatry Res. 2019 07; 277:45-51.
    View in: PubMed
    Score: 0.201
  3. Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia. Brain Imaging Behav. 2018 02; 12(1):229-237.
    View in: PubMed
    Score: 0.187
  4. Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis. Neuroimage Clin. 2020; 26:102108.
    View in: PubMed
    Score: 0.053
  5. Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis. Am J Psychiatry. 2019 10 01; 176(10):820-828.
    View in: PubMed
    Score: 0.051
  6. Alteration of gray matter microstructure in schizophrenia. Brain Imaging Behav. 2018 02; 12(1):54-63.
    View in: PubMed
    Score: 0.047
  7. Enlarged lateral ventricles inversely correlate with reduced corpus callosum central volume in first episode schizophrenia: association with functional measures. Brain Imaging Behav. 2016 12; 10(4):1264-1273.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.